Transactions in connection with share buyback programme
May 13, 2024 03:48 ET
|
ISS A/S
Company Announcement Copenhagen, 13 May 2024 No. 21/2024 Transactions in connection with share buyback programmeISS A/S, a leading workplace experience and facility...
Aktietilbagekøbsprogram - uge 19
May 13, 2024 02:52 ET
|
Ringkjøbing Landbobank A/S
Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinØvrige interessenter Dato 13.05.2024 Aktietilbagekøbsprogram - uge 19 Aktietilbagekøbsprogrammet løber i perioden fra og med den 1....
Share buy-back programme - week 19
May 13, 2024 02:52 ET
|
Ringkjøbing Landbobank A/S
Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinOther stakeholders Date 13.05.2024 Share buy-back programme - week 19 The share buy-back programme runs in the period 1 February 2024 up...
Subsea7 share repurchases
May 13, 2024 02:00 ET
|
Subsea 7 (Uk Service Co) Ltd
Luxembourg – 13 May 2024 - Subsea 7 S.A. (Oslo Børs: SUBC, ADR: SUBCY) today announced transactions made in accordance with its share repurchase programme during the week commencing 6 May...
Transaction in Own Shares
May 13, 2024 02:00 ET
|
ICG Enterprise Trust Plc
ICG Enterprise Trust plc (the “Company”) 13 May 2024 Transaction in Own Shares The Company announces that on 10 May 2024 it bought back 10,000 of its own shares, to be held as treasury shares, at...
Azucar Grants Stock Options
May 10, 2024 17:47 ET
|
Azucar Minerals Ltd.
VANCOUVER, British Columbia, May 10, 2024 (GLOBE NEWSWIRE) -- Azucar Minerals Ltd. ("Azucar" or the "Company") (TSX-V: AMZ; OTCQB: AXDDF) announces that, pursuant to its Stock Option Plan, it has...
Crinetics Pharmaceuticals Announces May 2024 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024 17:38 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, May 10, 2024 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on May 10, 2024, the Compensation Committee of Crinetics’ Board of Directors granted...
Ocugen Announces Distribution of Series C Preferred Stock to Holders of its Common Stock
May 10, 2024 16:05 ET
|
Ocugen
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024 16:05 ET
|
TELA Bio, Inc.
MALVERN, Pa., May 10, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction...
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 10, 2024 16:05 ET
|
89bio, Inc.
SAN FRANCISCO, May 10, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (the “Company” or “89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of...